Related references
Note: Only part of the references are listed.Mortality in a population-based cohort of patients treated with antiparkinsonian drugs
R. Raschetti et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Prospective case-control study of nonfatal cancer preceding the diagnosis of Parkinson's disease
Jane A. Driver et al.
CANCER CAUSES & CONTROL (2007)
Skin cancers and precancerous lesions in Parkinson's disease patients
Joaquim Ferreira et al.
MOVEMENT DISORDERS (2007)
A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease
Jane A. Driver et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Malignant melanoma in early Parkinson's disease: The DATATOP trial
Radu Constantinescu et al.
MOVEMENT DISORDERS (2007)
Mortality due to amyotrophic lateral sclerosis and Parkinson's disease among melanoma patients
P. D. Baade et al.
NEUROEPIDEMIOLOGY (2007)
Malignant melanoma and other types of cancer preceding Parkinson disease
Jorgen H. Olsen et al.
EPIDEMIOLOGY (2006)
Anatomic site, sun exposure, and risk of cutaneous melanoma
David C. Whiteman et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Risk of cancer after the diagnosis of Parkinson's disease: A historical cohort study
A Elbaz et al.
MOVEMENT DISORDERS (2005)
Atypical cancer pattern in patients with Parkinson's disease
JH Olsen et al.
BRITISH JOURNAL OF CANCER (2005)
Tumor diagnosis preceding Parkinson's disease: A case-control study
M D'Amelio et al.
MOVEMENT DISORDERS (2004)
Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence?
KH Fiala et al.
PARKINSONISM & RELATED DISORDERS (2003)
Nonfatal cancer preceding Parkinson's disease: A case-control study
A Elbaz et al.
EPIDEMIOLOGY (2002)
Malignant melanoma: Prevention, early detection, and treatment in the 21st Century
DS Rigel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2000)
Mortality and cancer incidence in patients with Parkinson's disease
Y Minami et al.
JOURNAL OF NEUROLOGY (2000)
Levodopa therapy and the risk of malignant melanoma
JF Siple et al.
ANNALS OF PHARMACOTHERAPY (2000)
Share Paper
